By-Health Patent Application.27 Mar 2024 09:23
"Plant extract composition and application thereof"
2024-03-22 Publication of CN117731721A
Status Pending
"5. The drug for preventing and treating cerebral thrombosis according to claim 4, wherein the dosage form of the drug is a tablet, a capsule or a powder."
"Cerebral thrombosis is one of common ischemic cerebrovascular diseases, and has high death rate and disability rate. The main harm of cerebral thrombosis is to cause vascular occlusion and blood flow interruption, so that cerebral tissues in blood supply areas of blood vessels are ischemic, anoxic, softened and necrotized, and the damage of nerve functions is caused, and the cerebral thrombosis is particularly manifested by hemiplegia, limb numbness, motor confusion, slurred speech, dizziness, blurred vision and the like, and the serious people can suffer from coma, fecal incontinence and even death. In recent years, the dietary structure is changed, the life rhythm is accelerated, cerebral thrombosis is shown to be an increasing incidence, and the ill population tends to be younger, thus bringing great threat to the health of the vast population."
"Compared with the traditional technology, the beneficial effects of the embodiment of the application include:
the plant extract composition comprising the water-soluble tomato concentrate and the ampelopsis grossedentata extract provided by the embodiment of the application has a synergistic effect in improving blood flow, inhibiting platelet aggregation and preventing cerebral thrombosis, and compared with the use of a single extract, the water-soluble tomato concentrate and the ampelopsis grossedentata extract are combined, so that the effect is remarkably improved, the cost is greatly reduced, and the application prospect is very good."
https://patents.google.com/patent/CN117731721A/en?oq=%22CN117731721A%22
Sign In
Follow the stocks
